These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 13907604)

  • 1. Ascite tumor fluid as a source of antibodies in mice.
    HIRAMOTO R; BERNECKY J; JURAND J
    Proc Soc Exp Biol Med; 1962; 110():895-7. PubMed ID: 13907604
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of prednisone and amphenone on fluid and electrolyte balance and on aldosterone excretion of patients with cirrhosis and ascites.
    STORMONT JM; CRABBE J; FAST B; WOLFE SJ; DAVIDSON CS
    J Lab Clin Med; 1959 Mar; 53(3):396-416. PubMed ID: 13631323
    [No Abstract]   [Full Text] [Related]  

  • 3. On the immunopathological specificity of tumor cells; observed by re- and cross-transplantation of rat ascites tumors in mice.
    TAKEDA K
    Gan; 1955 Dec; 46(4):567-84. PubMed ID: 13318220
    [No Abstract]   [Full Text] [Related]  

  • 4. THE DEMONSTRATION OF AN INHIBITOR OF ONCOLYSIS IN THE ASCITIC FLUID FROM THE EHRLICH ASCITES CARCINOMA.
    HARTVEIT F
    Br J Cancer; 1964 Dec; 18(4):726-9. PubMed ID: 14264938
    [No Abstract]   [Full Text] [Related]  

  • 5. IMMUNITY TO TRANSPLANTABLE TUMORS FOLLOWING VIRAL ONCOLYSIS. I. MECHANISM OF IMMUNITY TO EHRLICH ASCITES TUMOR.
    LINDENMANN J
    J Immunol; 1964 Jun; 92():912-9. PubMed ID: 14218302
    [No Abstract]   [Full Text] [Related]  

  • 6. THE EFFECTS OF ANTIBODIES ON CELLS. I. BIOCHEMICAL AND HISTOCHEMICAL EFFECTS OF ANTIBODIES AND COMPLEMENT ON ASCITES TUMOUR CELLS.
    DUMONDE DC; BITENSKY L; CUNNINGHAM GJ; CHAYEN J
    Immunology; 1965 Jan; 8(1):25-36. PubMed ID: 14245309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. THE EFFECTS OF ANTIBODIES ON CELLS. II. CHANGES IN THE ELECTROPHORETIC MOBILITY OF ASCITES TUMOUR CELLS TREATED WITH ANTIBODIES AND COMPLEMENT.
    FORRESTER JA; DUMONDE DC; AMBROSE EJ
    Immunology; 1965 Jan; 8(1):37-48. PubMed ID: 14245310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immuno-pathological studies on the specific antigenicity of tumor cells; observations on ascites tumors of rats.
    TAKEDA K
    Acta Unio Int Contra Cancrum; 1956; 12(1-2):156-68. PubMed ID: 13339545
    [No Abstract]   [Full Text] [Related]  

  • 9. CYTOPLASMIC MICROTUBULES IN MOUSE PERITONEAL MACROPHAGES DURING REJECTION OF MC1M ASCITES TUMOR CELLS.
    JOURNEY LJ
    Cancer Res; 1964 Sep; 24():1391-405. PubMed ID: 14221796
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the changes of antigenicity of ascites tumor and normal tissue of rat treated with several physical and chemical methods.
    HAYASHISHITA T; NAOE K; KAJI T; NAYA F; OGASAWARA K
    Gan; 1954 Sep; 45(2-3):361-4. PubMed ID: 13220901
    [No Abstract]   [Full Text] [Related]  

  • 11. Minocycline inhibits malignant ascites of ovarian cancer through targeting multiple signaling pathways.
    Pourgholami MH; Ataie-Kachoie P; Badar S; Morris DL
    Gynecol Oncol; 2013 Apr; 129(1):113-9. PubMed ID: 23274564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [STIMULATING EFFECT OF FILTRATE OF ASCITES FLUID ON THE GROWTH AND TRANSPLANTABILITY OF EHRLICH TUMOR CELLS].
    VASILEV IM
    Vopr Onkol; 1964; 10():3-6. PubMed ID: 14182986
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the influence of the tumor type specific antibody upon the chemotherapy of ascites tumors of rat.
    TAKEDA K
    Acta Unio Int Contra Cancrum; 1959; 15(Suppl 1)():279-80. PubMed ID: 13836670
    [No Abstract]   [Full Text] [Related]  

  • 14. Immuno-pathological studies on the characteristic antigenicity of ascites tumors of rat by formalin treatment.
    TAKEDA K; NAMBU M; TOZAWA T; HASHIMOTO T
    Gan; 1954 Sep; 45(2-3):350-4. PubMed ID: 13220897
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the stabilization of the specific antigenicity of rat ascites tumors by trichloroacetic acid treatment.
    TAKEDA K; YOSHIO H; HASHIMOTO T; SAKATA Y; KOBAYASHI H; HAYASHISHITA T; OGASAWARA K
    Gan; 1955 Sep; 46(2-3):140-3. PubMed ID: 13262302
    [No Abstract]   [Full Text] [Related]  

  • 16. THE ISOLATION AND COMPOSITION OF A CYTOTOXIC POLYPEPTIDE FROM TUMOR FLUIDS.
    HOLMBERG B
    Z Krebsforsch; 1964 Feb; 66():65-72. PubMed ID: 14154138
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanisms of fluid and electrolyte retention in experimental preparations in dogs. III. Effect of adrenalectomy and subsequent desoxycorticosterone acetate administration on ascites formation.
    DAVIS JO; HOWELL DS; SOUTHWORTH JL
    Circ Res; 1953 May; 1(3):260-70. PubMed ID: 13051849
    [No Abstract]   [Full Text] [Related]  

  • 18. RATE OF FORMATION AND LYMPHATIC REMOVAL OF FLUID IN ASCITES.
    IBER FL; MITRA PP
    Bull Calcutta Sch Trop Med; 1964 Apr; 12():51-3. PubMed ID: 14240684
    [No Abstract]   [Full Text] [Related]  

  • 19. Serologic analysis of Ehrlich tumor-cell induced ascites fluid.
    MIYA F; HILL GA; MARCUS S
    Proc Soc Exp Biol Med; 1959 Nov; 102():382-4. PubMed ID: 14423071
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on fluid media for the cultivation of mouse ascites tumour cells in vitro.
    POWELL AK
    Br J Cancer; 1960 Mar; 14(1):99-105. PubMed ID: 14434552
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.